-transparent.png){kind=logo}
The effects of three cannabinoids, 11-hydroxy-delta9-tetrahydrocannabinol (11-HO-delta9-THC), delta9-THC and cannabinol (CBN), ranging in behavioral activity from high to low, were studied on two aspects of pituitary--adrenal function. Plasma corticosterone levels were used as an index of adrenocorticotropic hormone (ACTH) release. All three cannabinoids elicited an increase in plasma corticosterone elvels in a manner similar to their behavioral potency. These cannabinoids also elicited an increase in the concentration of 3H-corticosterone taken up by the brains of adrenalectomized mice in a manner similar to their potency in elevating plasma corticosterone levels. The significance and possible underlying mechanism of the apparent correlation resulting between these effects and the behavioral effects of cannabinoids are discussed.
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
January 1978,
Annali dell'Istituto superiore di sanita,
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
January 1975,
Progress in brain research,
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
August 1991,
Ecotoxicology and environmental safety,
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
November 2006,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
July 1987,
Journal of steroid biochemistry,
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
May 1978,
Physiology & behavior,
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
April 1979,
Cell and tissue research,
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
August 1977,
Canadian journal of physiology and pharmacology,
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
October 1982,
Pharmacology, biochemistry, and behavior,
K M Johnson, and
W L Dewey, and
K S Ritter, and
J S Beckner
May 1966,
The Journal of pharmacy and pharmacology,
